Journal of the Chinese Medical Association
Volume 71, Issue 8 , Pages 416-420, August 2008

Acute Myeloid Leukemia Associated with Acute Myocardial Infarction and Dural Sinus Thrombosis: The Possible Role of Leukemia-related Hyperhomocysteinemia

  • Hung Chang

      Affiliations

    • Division of Hematology-Oncology, Chang Gung Memorial Hospital, Taipei, and Chang Gung University School of Medicine, Taoyuan, Taiwan, R.O.C.
    • ,
  • Tung-Liang Lin

      Affiliations

    • Division of Hematology-Oncology, Chang Gung Memorial Hospital, Taipei, and Chang Gung University School of Medicine, Taoyuan, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr Tung-Liang Lin, Division of Hematology-Oncology, Chang Gung Memorial Hospital, 199, Tung Hwa North Road, Taipei 105, Taiwan, R.O.C.
    • ,
  • Wan-Jing Ho

      Affiliations

    • Department of Cardiology, Chang Gung Memorial Hospital, Taipei, and Chang Gung University School of Medicine, Taoyuan, Taiwan, R.O.C.
    • ,
  • Lung-An Hsu

      Affiliations

    • Department of Cardiology, Chang Gung Memorial Hospital, Taipei, and Chang Gung University School of Medicine, Taoyuan, Taiwan, R.O.C.

Received 17 September 2007; accepted 27 March 2008.

Article Outline

The association of acute myeloid leukemia (AML) and acute myocardial infarction (AMI) is rare. We encountered a 40-year-old female with inferior wall myocardial infarction that occurred simultaneously with the diagnosis of AML. She developed subsequent dural sinus thrombosis during chemotherapy for AML. The screen for thrombophilia revealed that she had hyperhomocysteinemia. In the English literature, only 4 cases have been reported previously. Remission induction was not affected by the occurrence of AMI, although anthracyclines were avoided in all cases. In the absence of conventional risk factors for coronary artery disease, AMI can be related to leukemia per se and the role of homocysteine is worth further investigation.

Key Words:  acute myeloid leukemia , acute myocardial infarction , dural sinus thrombosis , homocysteine , thrombophilia

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Mattioli AV , Bonetti L , Zennaro M , Bertoncelli P , Mattioli G . Acute myocardial infarction in young patients: nutritional status and biochemical factors . Int J Cardiol . 2005;101:185–190
  2. Angeline T , Jeyaraj N , Tsongais GJ . MTHFR gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients . Exp Mol Pathol . 2007;82:227–233
  3. Solomons HD , Stanley A , King PC , Pienaar N , Atkinson PM . Acute promyelocytic leukaemia associated with acute myocardial infarction: a case report . S Afr Med J . 1986;70:117–118
  4. Cohen Y , Amir G , Da'as N , Gillis S , Rund D , Polliack A . Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis . Am J Hematol . 2002;71:47–49
  5. Pervez H , Potti A , Mehdi SA . Challenging and unusual cases: case 1. Simultaneous presentation of acute myelogenous leukemia and myocardial infarction . J Clin Oncol . 2003;21:1416–1417
  6. Jachmann-Jahn U, Cornely OA, Laufs U, Hopp HW, Meuthen I, Krakau M, et al. Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia . Ann Hematol . 2001;80:677–681
  7. Lisker SA , Finkelstein D , Brody JI , Beizer LH . Myocardial infarction in acute leukemia: report of a case in a young man . Arch Intern Med . 1967;119:532–535
  8. Dixit A , Kannan M , Mahapatra M , Choudhry VP , Saxena R . Roles of protein C, protein S, and antithrombin III in acute leukemia . Am J Hematol . 2006;81:171–174
  9. Verso M , Agnelli G . Venous thromboembolism associated with long-term use of central venous catheters in cancer patients . J Clin Oncol . 2003;21:3665–3675
  10. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project . JAMA . 1997;277:1775–1781
  11. Nygard O , Nordrehaug JE , Refsum H , Ueland PM , Farstad M , Vollset SE . Plasma homocysteine levels and mortality in patients with coronary artery disease . N Engl J Med . 1997;337:230–236
  12. Ho CH, Kuo BI, Kong CW, Chau WK, Hsu HC, Gau JP, et al. Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese . J Chin Med Assoc . 2005;68:560–565
  13. Sun CF , Haven TR , Wu TL , Tsao KC , Wu JT . Serum total homocysteine increases with the rapid proliferation rate of tumor cells and declines upon cell death: a potential new tumor marker . Clin Chim Acta . 2002;321:55–62
  14. Tallova J , Tomandl J , Bicikova M , Hill M . Changes of plasma total homocysteine levels during the menstrual cycle . Eur J Clin Invest . 1999;29:1041–1044

PII: S1726-4901(08)70093-5

doi:10.1016/S1726-4901(08)70093-5

Journal of the Chinese Medical Association
Volume 71, Issue 8 , Pages 416-420, August 2008

Article Tools